 |
|
|
| |
INTERFERON-FREE TREATMENT WITH FALDAPREVIR, DELEOBUVIR (BI 207127) AND RIBAVIRIN IN SOUND-C3: 95% SVR12 IN HCV-GT1B
|
| |
| |
Reported by Jules Levin
APASL Liver Week, Singapore 6-9 June, 2013
S Zeuzem1, J-F Dufour2, M Buti3, V Soriano4, R Buynak5, P Mantry6, J Taunk7, JO Stern8, R Vinisko8, J-P Gallivan9, WO Bocher9 and FJ Mensa8
1JW Goethe-Universitat, Frankfurt am Main, Germany; 2Hepatology, University Clinic for Visceral Surgery and Medicine, Bern, Switzerland; 3Hospital Vall d'Hebron and CIBERehd, Barcelona, Spain; 4Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain; 5Northwest Indiana Center for Clinical Research, Valparaiso, IN, USA; 6The Liver Institute at Methodist Dallas Medical Center, Dallas, TX, USA; 7Advance Gastroenterology Associates, LLC, Palm Harbor, FL, USA; 8Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA; 9Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
|
| |
|
|
|
|
|
